CONTACT US   |  (864) 397-5101

SCBio launches new life sciences business accelerator program

SCBio, the state’s premiere life sciences industry association and economic development group, announced the launch of a new accelerator program for emerging life sciences companies at the organization’s annual conference in Greenville last month.

The new program, SCbioDrive, is in partnership with MassBio, SCBio’s Massachusetts counterpart, and will offer companies expert business curricula, industry guidance and mentorship.

The program is patterned after MassBioDrive, and the collaboration reflects the huge potential SCBio’s Massachusetts counterparts see for the growth of life sciences companies in the Palmetto State, according to James Chappell, SCBio’s president and CEO.

“They see the growth potential in South Carolina,” he said. “We want this program to show entrepreneurs that South Carolina is the state where businesses, at their earliest stages, are set up for success and sustained growth.”

A biannual program, SCbioDrive will select up to six seed-stage therapeutic- and medical-device companies for an eight-week course, which will consist of seven weeks of virtual instruction followed by one week in person at SCbio facilities in Charleston. Company founders will complete industry-specific curriculum modules, led by experts from leading companies within the Palmetto State, which will include:

  • Business planning and commercialization
  • Fundraising
  • People strategy and operations
  • Drug discovery and therapeutics
  • Intellectual property and legal
  • Regulatory strategy
  • Business scaling

The program will conclude with an in-person demo day.

“Our vision for Drive has always been to support diverse founders with exciting science no matter where they are starting their company,” said MassBio CEO and President Kendalle Burlin O’Connell. “We’re pleased to see SCbio take the MassBioDrive model and put a Palmetto State spin on it to accelerate their homegrown startups toward success.”

SCbioDrive will launch this fall. Applications for the inaugural program cohort will be available in June at

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.